Study critiques the World Health Organization’s fungal priority pathogens list for not fully reflecting the global burden of fungal diseases, advocating for a revised list that considers regional disparities and elevates the priority of pathogens like Mucorales and Histoplasma spp. to better align with their impact on public health.
How gene therapy trials are cutting trial database costs by 30%
Merative’s Zelta platform has been instumental to Veristat optimising costs and timelines. Image credit: fizkes via Shutterstock. The gene therapy market is predicted to experience rapid growth
July 17, 2024